Cercar
28/03/2024
Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study
Kassubek, J, Factor, SA, Balaguer, E, Schwarz, J, Chaudhuri, KR, Isaacson, SH, Wu, S, Muhr, CD, Kulisevsky, J. Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study. JOURNAL OF NEUROLOGY. 2024; 271(6)DOI:10.1007/s00415-024-12323-2. PMID:38546829. IF:4.600(Q1/2D).
27/03/2024
Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease
Martinez-Horta, S, Perez-Perez, J, Perez-Gonzalez, R, Sampedro, F, Horta-Barba, A, Campolongo, A, Rivas-Asensio, E, Puig-Davi, A, Pagonabarraga, J, Kulisevsky, J. Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease. Annals of Clinical and Translational Neurology. 2024; 11(5)DOI:10.1002/acn3.52031. PMID:38544341. IF:3.900(Q1/3D).
27/01/2024
Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale
Garon, M, Weis, L, Siquier, A, Fiorenzato, E, Pistonesi, F, Cianci, V, Canesi, M, Pesce, F, Reali, E, Pozzi, B, Isaias, IU, Siri, C, Santangelo, G, Cuoco, S, Barone, P, Kulisevsky, J, Antonini, A, Biundo, R. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale. JOURNAL OF NEURAL TRANSMISSION. 2024; 131(4)DOI:10.1007/s00702-024-02746-6. PMID:38280057. IF:4.000(Q1/2D).
15/01/2024
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms
Pagonabarraga, J, Bejr-Kasem, H, Martinez-Horta, S, Kulisevsky, J. Parkinson disease psychosis: from phenomenology to neurobiological mechanisms. Nature Reviews Neurology. 2024; 20(3)DOI:10.1038/s41582-023-00918-8. PMID:38225264. IF:33.100(Q1/1D).
02/01/2024
Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal-Lobe Signs
Ruiz-Barrio, I, Horta-Barba, A, Aracil-Bolaños, I, Martinez-Horta, S, Kulisevsky, J, Pagonabarraga, J. Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal-Lobe Signs. Movement Disorders Clinical Practice. 2024; 11(3)DOI:10.1002/mdc3.13958. PMID:38164060. IF:2.700(Q2/5D).
01/01/2024
Baseline Large-Scale Network Dynamics Associated with Disease Progression in Huntington's Disease
Aracil-Bolaños, I, Pérez-Pérez, J, Martínez-Horta, S, Horta-Barba, A, Puig-Davi, A, Garcia-Cornet, J, Olmedo-Saura, G, Campolongo, A, Pagonabarraga, J, Kulisevsky, J. Baseline Large-Scale Network Dynamics Associated with Disease Progression in Huntington's Disease. MOVEMENT DISORDERS. 2024; 39(1)DOI:10.1002/mds.29655. PMID:38148511. IF:7.600(Q1/1D).
01/01/2024
Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease
Rodríguez-Antigüedad J., Martínez-Horta S., Horta-Barba A., Puig-Davi A., Campolongo A., Sampedro F., Bejr-Kasem H., Marín-Lahoz J., Pagonabarraga J., Kulisevsky J.. Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease. JOURNAL OF NEURAL TRANSMISSION. 2024; 131(12)DOI:10.1007/s00702-023-02725-3. PMID:38206439. IF:4.000(Q1/2D).
09/12/2023
The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson's Disease
Cattaneo, C, Kulisevsky, J. The Effects of Safinamide in Chinese and Non-Chinese Patients with Parkinson's Disease. ADVANCES IN THERAPY. 2023; DOI:10.1007/s12325-023-02736-2. PMID:38070039. IF:3.400(Q2/3D).
08/11/2023
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden
Santos-García, D, Fonticoba, TD, Bartolomé, CC, Painceiras, MJF, Díaz, IG, Alvarado, MCI, Paz, JM, Jesús, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, García-Soto, JD, Borrué, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordás, C, Menéndez-González, M, Mcafee, D, Martinez-Martin, P, Mir, P, COPPADIS Study Grp. Staging Parkinson's disease according to the MNCD classification correlates with caregiver burden. Brain and Behavior. 2023; 13(12)DOI:10.1002/brb3.3295. PMID:37939322. IF:2.600(Q2/3D).
14/09/2023
Impact of Infusion Therapies on Quality of Life in Advanced Parkinson's Disease.
Constantin VA, Szász JA, Dulamea AO, Valkovic P, Kulisevsky J. Impact of Infusion Therapies on Quality of Life in Advanced Parkinson's Disease.. Neuropsychiatric Disease and Treatment. 2023; 19DOI:10.2147/NDT.S422717. PMID:37727253. IF:2.500(Q2/5D).
14/08/2023
Cognitive impairment and dementia in young onset Parkinson’s disease
Santos-García D., Cores Bartolomé C., Feal Painceiras M.J., García Díaz I., Íñiguez Alvarado M.C., Paz J.M., García Caldentey J., Hernández Vara J., Cabo I., López Manzanares L., González Aramburu I., Ávila Rivera M.A., Gómez Mayordomo V., Dotor García-Soto J., Borrué C., Solano Vila B., Álvarez Sauco M., Mendoza Z., Martínez Castrillo J.C., Sánchez Alonso P., Alonso Losada M.G., López Ariztegui N., Alonso Redondo R., Menéndez-González M., Adarmes A.D., Almeria M., Losada M.G.A., Cánovas A.A., Frech F.A., Redondo R.A., Álvarez I., Sauco M.Á., Díaz A.A., Arnáiz S., Arribas S., Vidondo A.A., Aguilar M., Ávila M.A., Lambrich N.N., Bejr-Kasem H., Estrada M.B., Botí M., Borrue C., Buongiorno M.T., González C.C., López I.C., Caballol N., Lorenzo A.C., Medina H.C., Pendón E.C., Carrillo F., Padilla F.J.C., Casas E., Catalán M.J., Clavero P., Fernández A.C., Cosgaya M., Foraster A.C., Cuevas A.C., Cubo E., de Deus Fonticoba T., de Fábregues-Boixar O., Díez-Fairen M., García-Soto J.D., Erro E., Escalante S., Peyret E.E., Guillán N.F., Gámez P., Gallego M., Caldentey J.G., Campos C.G., Díez C.G., Moreno J.M.G., Gastón I., Garre M.P.G., Mayordomo V.G., Aloy J.G., González-Aramburu I., Ardura J.G., García B.G., Palmás M.J.G., Toledo G.R.G., Díaz A.G., Solá M.G., Guardia G., Vara J.H., Horta-Barba A., Calderón D.I., Infante J., Jesús S., Kulisevsky J., Kurtis M., Labandeira C., Labrador M.A., Lacruz F., Castro M.L., Gómez S.L., Legarda I., Ariztegui N.L., Díaz L.M.L., Domínguez D.L., Manzanares L.L., Seoane B.L., del Pozo S.L., Macías Y., Mata M., Andres G.M., Martí M.J., Castrillo J.C.M., Martinez-Martin P., McAfee D., Meitín M.T., Plasencia Z.M., González M.M., del Barrio C.M., Mir P., Santiago J.M., Casado M.I.M., Diéguez A.M., García I.M., Nogueira V., Amado A.N., Ponte S.N., Ordás C., Pagonabarraga J., Pareés I., Pascual-Sedano B., Pastor P., Fuertes A.P., Noguera R.P., Planas-Ballvé A., Planellas L., Prats M.A., Jurczynska C.P., Puente V., Morlans M.P., Daví A.P., Rafales N.R., Méndez L.R., Pérez A.B.R., Roldán F., De Arcos M.R., Martínez J.R., Alonso P.S., Sánchez-Carpintero M., Díez G.S., Rodríguez A.S., Santacruz P., García D.S., Rodríguez J.C.S., Seijo M., Peña M.S., Vila B.S., Castro E.S., Tartari J.P., Valero C., Vargas L., Vela L., Villanueva C.. Cognitive impairment and dementia in young onset Parkinson’s disease. JOURNAL OF NEUROLOGY. 2023; DOI:10.1007/s00415-023-11921-w. PMID:37578489. IF:4.800(Q1/2D).
18/07/2023
Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instruments
Horta-Barba, A, Martinez-Horta, S, Perez-Perez, J, Puig-Davi, A, de Lucia, N, de Michele, G, Salvatore, E, Kehrer, S, Priller, J, Migliore, S, Squitieri, F, Castaldo, A, Mariotti, C, Mananes, V, Lopez-Sendon, JL, Rodriguez, N, Martinez-Descals, A, Julio, F, Januaario, C, Delussi, M, de Tommaso, M, Noguera, S, Ruiz-Idiago, J, Sitek, EJ, Wallner, R, Nuzzi, A, Pagonabarraga, J, Kulisevsky, J. Measuring cognitive impairment and monitoring cognitive decline in Huntington's disease: a comparison of assessment instruments. JOURNAL OF NEUROLOGY. 2023; 270(11)DOI:10.1007/s00415-023-11804-0. PMID:37462754. IF:4.800(Q1/2D).
17/07/2023
Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review
Olszewska, DA, Shetty, A, Rajalingam, R, Rodriguez-Antiguedad, J, Hamed, M, Huang, JA, Breza, M, Rasheed, A, Bahr, N, Madoev, H, Westenberger, A, Trinh, J, Lohmann, K, Klein, C, Marras, C, Waln, O. Genotype-phenotype relations for episodic ataxia genes: MDSGene systematic review. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(10)DOI:10.1111/ene.15969. PMID:37422902. IF:4.500(Q1/2D).
13/07/2023
Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines
Kulisevsky J., Falup-Pecurariu C., Santens P., Jost W.H.. Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines. JOURNAL OF NEURAL TRANSMISSION. 2023; 130(11)DOI:10.1007/s00702-023-02664-z. PMID:37439943. IF:3.200(Q2/3D).
01/07/2023
Understanding visual hallucinations: A new synthesis
Collerton, D, Barnes, J, Diederich, NJ, Dudley, R, Ffytche, D, Friston, K, Goetz, CG, Goldman, JG, Jardri, R, Kulisevsky, J, Lewis, SJG, Naral, S, O'Callaghan, C, Onofrj, M, Pagonabarraga, J, Parr, T, Shine, JM, Stebbins, G, Taylor, JP, Tsuda, I, Weil, RS. Understanding visual hallucinations: A new synthesis. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2023; 150DOI:10.1016/j.neubiorev.2023.105208. PMID:37141962. IF:7.600(Q1/1D).
01/07/2023
Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints
Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Gonzalez, JMP, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LMLL, McAfee, D, Martinez-Martin, P, Mir, P. Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints. Journal of Clinical Neurology. 2023; 19(4)DOI:10.3988/jcn.2022.0186. PMID:36647231. IF:3.000(Q2/4D).
21/06/2023
Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report
Collet-Vidiella, R, Olmedo-Saura, G, Ruiz-Barrio, I, Martinez-Viguera, A, Rodriguez-Santiago, B, Bernal, S, Kulisevsky, J, Pagonabarraga, J. Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report. Movement Disorders Clinical Practice. 2023; 10(8)DOI:10.1002/mdc3.13811. PMID:37635772. IF:2.600(Q2/5D).
16/06/2023
Essential tremor: are we just splitting hairs? Non-motor symptoms and essential tremor-plus
Gironell, A. Essential tremor: are we just splitting hairs? Non-motor symptoms and essential tremor-plus. REVISTA DE NEUROLOGIA. 2023; 76(12)DOI:10.33588/rn.7612.2023083. PMID:37303101. IF:0.800(Q4/9D).
01/06/2023
Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease
Horta-Barba A., Martinez-Horta S., Sampedro F., Pérez-Pérez J., Pagonabarraga J., Kulisevsky J.. Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease. JOURNAL OF NEUROSCIENCE RESEARCH. 2023; 101(6)DOI:10.1002/jnr.25174. PMID:36807154. IF:2.900(Q2/5D).
01/05/2023
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease
Gamez, J, Calopa, M, Munoz, E, Ferre, A, Huertas, O, McAllister, K, Reig, N, Scart-Gres, C, Insa, R, Kulisevsky, J. A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2023; 89(5)DOI:10.1111/bcp.15635. PMID:36494329. IF:3.100(Q2/4D).
01/05/2023
Suicidal ideation among people with Parkinson's disease and comparison with a control group
Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Panceiras, MJF, Diaz, IG, Alvarado, MCI, Jesus, S, Boungiorno, MT, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P. Suicidal ideation among people with Parkinson's disease and comparison with a control group. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2023; 38(5)DOI:10.1002/gps.5919. PMID:37147900. IF:3.600(Q1/3D).
01/05/2023
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease
Kulisevsky, J, Martinez-Horta, S, Campolongo, A, Pascual-Sedano, B, Marin-Lahoz, J, Bejr-kasem, H, Labandeira-Garcia, JL, Lanciego, JL, Puig-Davi, A, Horta-Barba, A, Pagonabarraga, J, Rodriguez-Antiguedad, J. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2023; 110DOI:10.1016/j.parkreldis.2023.105367. PMID:36963339. IF:3.100(Q2/4D).
23/04/2023
Inhaled levodopa for threatening impending OFF episodes in managing Parkinson's disease
Jost, WH, Kulisevsky, J, LeWitt, PA. Inhaled levodopa for threatening impending OFF episodes in managing Parkinson's disease. JOURNAL OF NEURAL TRANSMISSION. 2023; 130(6)DOI:10.1007/s00702-023-02636-3. PMID:37087697. IF:3.200(Q2/3D).
17/04/2023
Cerebellar Syndrome Induced by Hypomagnesemia: A Treatable Cause of Ataxia Not to be Missed. Report of Three Cases and a Review of the Literature
Olmedo-Saura, G, Perez-Perez, J, Xucla-Ferrarons, T, Collet, R, Martinez-Viguera, A, Kulisevsky, J. Cerebellar Syndrome Induced by Hypomagnesemia: A Treatable Cause of Ataxia Not to be Missed. Report of Three Cases and a Review of the Literature. Movement Disorders Clinical Practice. 2023; 10(6)DOI:10.1002/mdc3.13739. PMID:37332648. IF:2.600(Q2/5D).
14/04/2023
Divergent cognitive trajectories in early stage Huntington's disease: A 3-year longitudinal study
Martinez-Horta, S, Perez-Perez, J, Oltra-Cucarella, J, Sampedro, F, Horta-Barba, A, Puig-Davi, A, Pagonabarraga, J, Kulisevsky, J. Divergent cognitive trajectories in early stage Huntington's disease: A 3-year longitudinal study. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(7)DOI:10.1111/ene.15806. PMID:36994811. IF:4.500(Q1/2D).
06/04/2023
Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
Santos-García D., Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Iniguez-Alvarado, MC, Jesús S., Buongiorno M.T., Planellas L., Cosgaya M., Caldentey, JG, Caballol N., Legarda I., Vara, JH, Cabo I., Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira V., Puente V., Garcia-Soto, JD, Borrué C., Vila, BS, Sauco, MA, Vela L., Escalante S., Cubo E., Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón I., Kulisevsky J., Estrada, MB, Seijo M., Martinez, JR, Valero C., Kurtis M., De Fábregues O., Ardura, JG, Redondo, RA, Ordás C., Diaz, LMLL, McAfee D., Martinez-Martin P., Mir P., Coppadis S.G.. Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group. Parkinsons Disease. 2023; 2023DOI:10.1155/2023/3104425. PMID:37065970. IF:2.100(Q3/6D).
08/03/2023
Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study
Alonso-Canovas, A, Kurtis, MM, Gomez-Mayordomo, V, Macias-Garcia, D, Viedma, AG, Rezola, EM, Pagonabarraga, J, Orgaz, LA, Masjuan, J, Martinez-Castrillo, JC, Parees, I. Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2023; 94(9)DOI:10.1136/jnnp-2022-330885. PMID:36889911. IF:8.800(Q1/1D).
07/03/2023
Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy
Barrio, IR, Miki, Y, Jaunmuktane, ZT, Warner, T, De Pablo-Fernandez, E. Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy. NEUROLOGY. 2023; 100(10)DOI:10.1212/WNL.0000000000201659. PMID:36526431. IF:8.400(Q1/1D).
01/03/2023
Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil
Brandao, PRD, Pereira, DA, Grippe, TC, Bispo, DDD, Maluf, FB, Yunes, MP, Nunes, G, Alves, CHL, Pagonabarraga, J, Kulisevsky, J, da Costa, AML, Serafim, CFD, Ferreira, ACD, Bastos, ADM, Belchior, ACF, de Almeida, BLC, Castro, BMDE, Matos, MS, de Matos, RC, Rios, GD, Carneiro, LO, da Mota, BCC, Castro, LED, Rocha, VLS, Tavares, MCH, Cardoso, F. Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil. Movement Disorders Clinical Practice. 2023; 10(3)DOI:10.1002/mdc3.13657. PMID:36949793. IF:2.600(Q2/5D).
01/02/2023
Lamin B1 and nuclear morphology in peripheral cells as new potential biomarkers to follow treatment response in Huntington's disease
Garcia-Forn, M, Castany-Pladevall, C, Golbano, A, Perez-Perez, J, Brito, V, Kulisevsky, J, Perez-Navarro, E. Lamin B1 and nuclear morphology in peripheral cells as new potential biomarkers to follow treatment response in Huntington's disease. Clinical and Translational Medicine. 2023; 13(2)DOI:10.1002/ctm2.1154. PMID:36781300. IF:7.900(Q1/1D).
01/02/2023
Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders
Pagonabarraga, J, Alamo, C, Castellanos, M, Diaz, S, Manzano, S. Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders. Brain Sciences. 2023; 13(2)DOI:10.3390/brainsci13020318. PMID:36831861. IF:2.700(Q3/6D).
01/02/2023
Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson's Disease
Santos-Garcia, D, Laguna, A, Hernandez-Vara, J, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Iniguez-Alvarado, MC, Diaz, IG, Jesus, S, Boungiorno, MT, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Gonzalez, MM, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P. Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson's Disease. Journal of Clinical Medicine. 2023; 12(4)DOI:10.3390/jcm12041329. PMID:36835866. IF:3.000(Q1/2D).
01/01/2023
Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease
Gil-Polo, C, Martinez-Horta, SI, Santalo, FS, Martin-Palencia, M, Gundin-Menendez, S, Alvarez-Banos, P, Maza-Pereg, L, Calvo, S, Collazo, C, Alonso-Garcia, E, Rinones-Mena, E, Arrabal-Alonso, A, Rodriguez, JN, Saiz-Rodriguez, M, Aguado, L, Mariscal, N, Munoz-Siscart, I, Pineiro, D, Rivadeneyra, J, Diez-Fairen, M, Miguel-Perez, I, Cubo, E. Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease. Movement Disorders Clinical Practice. 2023; 10(2)DOI:10.1002/mdc3.13613. PMID:36825059. IF:2.600(Q2/5D).
01/01/2023
Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson's disease
Sampedro F., Puig-Davi A., Martinez-Horta S., Pagonabarraga J., Horta-Barba A., Aracil-Bolaños I., Kulisevsky J.. Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson's disease. CLINICAL NEUROLOGY AND NEUROSURGERY. 2023; 224DOI:10.1016/j.clineuro.2022.107531. PMID:36455303. IF:1.800(Q2/5D).
01/01/2023
Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness
Santos-García D., Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Iniguez-Alvarado, MC, Diaz, IG, Jesús S., Buongiorno M.T., Planellas L., Cosgaya M., Caldentey, JG, Caballol N., Legarda I., Vara, JH, Cabo I., Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira V., Puente V., Garcia-Soto, JD, Borrué C., Vila, BS, Sauco, MA, Vela L., Escalante S., Cubo E., Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gastón I., Kulisevsky J., Gonzalez, MM, Seijo M., Martinez, JR, Valero C., Kurtis M., Ardura, JG, Redondo, RA, Ordás C., Diaz, LML, McAfee D., Martinez-Martin P., Mir P.. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness. Journal of Parkinsons Disease. 2023; 13(2)DOI:10.3233/JPD-225014. PMID:36683517. IF:4.000(Q2/3D).
01/01/2023
Background Music and Memory in Mild Cognitive Impairment: The Role of Interindividual Differences
Calabria M., Ciongoli F., Grunden N., Ordás C., García-Sánchez C.. Background Music and Memory in Mild Cognitive Impairment: The Role of Interindividual Differences. JOURNAL OF ALZHEIMERS DISEASE. 2023; 92(3)DOI:10.3233/JAD-221051. PMID:36806508. IF:3.400(Q2/4D).
01/01/2023
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/ Dependency) Classification Correlates with Disease Severity and Quality of Life
Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Iniguez-Alvarado, MC, Diaz, IG, Jesus, S, Buongiorno, MT, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Sotos, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Gonzalez, MM, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Calopa, M, Carrillo, F, Sevilla, FE, Freire-Alvarez, E, Esteban, JCG, Ramos, RG, Luquin, MRI, Martinez-Torres, I, Ignacio, AS, Martinez-Martin, P, Mir, P. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/ Dependency) Classification Correlates with Disease Severity and Quality of Life. Journal of Parkinsons Disease. 2023; 13(3)DOI:10.3233/JPD-225073. PMID:36911948. IF:4.000(Q2/3D).
01/01/2023
Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease
Martínez M., Ariz M., Alvarez I., Castellanos G., Aguilar M., Hernández-Vara J., Caballol N., Garrido A., Bayés À., Vilas D., Marti M.J., Pascual-Sedano B., Marin J., Avila A., Buongiorno M., Tartari J.P., Puente V., Ezquerra M., Valldeoriola F., Compta Y., Tolosa E., Pont C., Pastor P., de Solórzano C.O., Pastor M.A.. Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson’s disease. npj Parkinsons Disease. 2023; 9(1)DOI:10.1038/s41531-023-00503-2. PMID:37061532. IF:6.700(Q1/1D).
16/12/2022
Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures
Ferraro, PM, Spotorno, N, Finegan, E, Sampedro, F, Caso, F. Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.1100953. PMID:36588898. IF:3.400(Q2/5D).
01/12/2022
Delineating apathy profiles in Huntington's disease with the short-Lille Apathy Rating Scale
De Paepe, AE, Garcia-Gorro, C, Martinez-Horta, S, Perez, JP, Kulisevsky, J, Rodriguez-Dechicha, N, Vaquer, I, Subira, S, Calopa, M, Santacruz, P, Munoz, E, Mareca, C, Ruiz-Idiago, J, De Diego-Balaguer, R, Camara, E. Delineating apathy profiles in Huntington's disease with the short-Lille Apathy Rating Scale. PARKINSONISM & RELATED DISORDERS. 2022; 105DOI:10.1016/j.parkreldis.2022.10.025. PMID:36395542. IF:4.100(Q2/3D).